John M. Hamm
CIK: 0001870439
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CUMBERLAND PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Mar 18, 2026CPIX
CUMBERLAND PHARMACEUTICALS INC
Award(A)DirectOptions (right to buy)
3K shares at avg. $2.80- - Mar 17, 2025CPIX
CUMBERLAND PHARMACEUTICALS INC
Award(A)DirectOptions (right to buy)
2.8K shares at avg. $5.17- - Mar 16, 2025CPIX
CUMBERLAND PHARMACEUTICALS INC
Tax Payment(F)Direct5.9K shares at avg. $5.46$32K
1-3 of 3 transactions
About Hamm John M.
Hamm John M. (SEC CIK 0001870439) files insider reports with the SEC as VP Chief Financial Officer of CUMBERLAND PHARMACEUTICALS INC (CPIX).
Signal8 holds 2 ownership filings by Hamm John M., all Form 4s, filed between Mar 18, 2025 and Mar 20, 2026. Those filings report 3 transactions, from Mar 16, 2025 to Mar 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hamm John M.'s filings is in NASHVILLE, TN.
Recent filings by Hamm John M.
Other insiders filing for CUMBERLAND PHARMACEUTICALS INC (CPIX)
- Brown Martin S JR, Director
- Galante Joseph C, Director
- Jones James, Director
- Krogulski Kenneth, Director
- Young Caroline, Director
- Anthony Todd M., Vice Pres Organizational Dev